• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌治疗的两种最常见的长期副作用:勃起功能障碍和下尿路症状/尿失禁的管理。

Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment.

机构信息

Division of Urology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

Can J Urol. 2020 Feb;27(27 Suppl 1):17-24.

PMID:32101696
Abstract

The two major long-term concerns associated with different options for the management of prostate cancer, (including surgery, radiotherapy, brachytherapy, cryotherapy, HIFU, etc.) include difficulties with lower urinary tract symptoms (LUTS) and/or erectile dysfunction. LUTS can be in the form of stress urinary incontinence (SUI), urge urinary incontinence (UUI), frequency/urgency, and/or voiding difficulties. While surgery is mostly associated with SUI and radiation mostly results in UUI, there can be an overlap. Incontinence rates after cryotherapy and high intensity focused ultrasound (HIFU) are generally very low. Voiding difficulties can also happen after the above-mentioned options. Treatment of SUI can start with pelvic floor muscle exercises (PFME), penile clamps or urethral plugs. If these fail to provide satisfactory results the surgical options could include: urethral bulking agents, male slings, and artificial urinary sphincter (AUS). Surgical options are usually not recommended during the first 6-12 months after radical prostatectomy. Management of frequency, urgency and/or UUI can also be started with lifestyle modifications and PFME. Oral agents (anticholinergics and β3-agonists) are also considered before proceeding to third line options, such as Botox injection or sacral neuromodulation. The treatment options for ED resulting from the treatment of prostate cancer can include oral PDE5-I as the first line, local therapy as the second (such as MUSE, intracavernosal injections, and perhaps low intensity shock wave therapy) and finally surgery as the third line. Standard questionnaires and patient reported outcome measurement tools should be used for the assessment of LUTS and erectile dysfunction prior and after initiation of treatment to guide the management.

摘要

与前列腺癌管理的不同选择(包括手术、放疗、近距离治疗、冷冻治疗、高强度聚焦超声等)相关的两个主要长期问题是下尿路症状(LUTS)和/或勃起功能障碍。LUTS 可以表现为压力性尿失禁(SUI)、急迫性尿失禁(UUI)、尿频/尿急和/或排尿困难。手术主要与 SUI 相关,放疗主要导致 UUI,但两者可能存在重叠。冷冻治疗和高强度聚焦超声(HIFU)后的尿失禁发生率通常非常低。上述选择后也可能出现排尿困难。SUI 的治疗可以从骨盆底肌肉锻炼(PFME)、阴茎夹或尿道塞开始。如果这些方法不能提供满意的效果,可以选择手术治疗,包括尿道填充剂、男性吊带和人工尿道括约肌(AUS)。根治性前列腺切除术后的前 6-12 个月通常不建议选择手术治疗。通过生活方式改变和 PFME 也可以开始治疗尿频、尿急和/或 UUI。在考虑三线治疗,如肉毒杆菌毒素注射或骶神经调节之前,还可以考虑口服药物(抗胆碱能药物和β3-激动剂)。前列腺癌治疗引起的 ED 治疗选择可以包括口服 PDE5-I 作为一线治疗,局部治疗作为二线(如 MUSE、阴茎内注射,以及可能的低强度冲击波治疗),最后是手术作为三线治疗。在开始治疗之前和之后,应使用标准问卷和患者报告的结局测量工具评估 LUTS 和勃起功能障碍,以指导治疗管理。

相似文献

1
Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment.前列腺癌治疗的两种最常见的长期副作用:勃起功能障碍和下尿路症状/尿失禁的管理。
Can J Urol. 2020 Feb;27(27 Suppl 1):17-24.
2
[Urinary and sexual disorders following localised prostate cancer management].[局限性前列腺癌治疗后的泌尿和性功能障碍]
Bull Cancer. 2010 Dec;97(12):1537-49. doi: 10.1684/bdc.2010.1229.
3
[Functional results and treatment of functional dysfunctions after radical prostatectomy].[根治性前列腺切除术后功能障碍的功能结果与治疗]
Prog Urol. 2015 Nov;25(15):1028-66. doi: 10.1016/j.purol.2015.07.013.
4
[Erectile dysfunction and incontinence after prostatectomy. Treating the complications of surgery for prostate cancer].前列腺切除术后的勃起功能障碍和尿失禁。治疗前列腺癌手术并发症
Ned Tijdschr Geneeskd. 2012;156(44):A4667.
5
Overactive bladder syndrome and lower urinary tract symptoms after prostate cancer treatment.前列腺癌治疗后的膀胱过度活动症和下尿路症状
Curr Opin Urol. 2017 May;27(3):307-313. doi: 10.1097/MOU.0000000000000391.
6
Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy.机器人辅助前列腺根治术后综合下尿路症状和各种类型尿失禁的纵向变化。
Neurourol Urodyn. 2019 Apr;38(4):1067-1075. doi: 10.1002/nau.23952. Epub 2019 Mar 14.
7
Combined Implantation of a Penile Prosthesis and Adjustable Continence Therapy ProACT in Patients with Erectile Dysfunction and Urinary Incontinence after Radical Prostatectomy: Results of a Prospective Pilot Study.阴茎假体与可调节控尿疗法ProACT联合植入治疗前列腺癌根治术后勃起功能障碍和尿失禁患者:一项前瞻性试点研究的结果
J Sex Med. 2015 Dec;12(12):2481-4. doi: 10.1111/jsm.13059. Epub 2015 Nov 27.
8
A clinical overview of the treatment of post-prostatectomy incontinence.前列腺切除术后尿失禁治疗的临床概述
Br J Nurs. 2007;16(19):1194-9. doi: 10.12968/bjon.2007.16.19.27357.
9
Male urinary incontinence after prostate disease treatment.前列腺疾病治疗后男性尿失禁。
Can J Urol. 2020 Aug;27(S3):36-43.
10
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.

引用本文的文献

1
Prospective Comparative Study of EMSella Therapy and Surgical Anterior Colporrhaphy for Urinary Incontinence: Outcomes and Efficacy.用于治疗尿失禁的电磁式阴道括约肌刺激疗法与外科前路阴道修补术的前瞻性对照研究:结果与疗效
Healthcare (Basel). 2025 Apr 10;13(8):864. doi: 10.3390/healthcare13080864.
2
Androgen deprivation therapy does not increase rates for reintervention, complication, or infection in primary penile implant or artificial urinary sphincter surgery: a retrospective cohort study from the TriNetX network.雄激素剥夺疗法不会增加原发性阴茎植入或人工尿道括约肌手术的再次干预、并发症或感染发生率:一项来自TriNetX网络的回顾性队列研究。
Int J Impot Res. 2025 Jan 29. doi: 10.1038/s41443-025-01015-8.
3
Ejaculation preserving TURP (Ep-TURP): A viable alternative in sexually active males with BOO-a single centre prospective randomized study.
射精功能保留经尿道前列腺切除术(Ep-TURP):在有 BOO 的活跃男性中的一种可行选择:单中心前瞻性随机研究。
World J Urol. 2024 Oct 8;42(1):567. doi: 10.1007/s00345-024-05276-8.
4
The Experiences and Perspectives of Persons with Prostate Cancer and Their Partners: A Qualitative Evidence Synthesis Using Meta-Ethnography.前列腺癌患者及其伴侣的经历与观点:一项运用元民族志的定性证据综合分析
Healthcare (Basel). 2024 Jul 27;12(15):1490. doi: 10.3390/healthcare12151490.
5
Disparities in the Delivery of Prostate Cancer Survivorship Care in the USA: A Claims-based Analysis of Urinary Adverse Events and Erectile Dysfunction Among Prostate Cancer Survivors.美国前列腺癌幸存者护理服务的差异:基于索赔数据对前列腺癌幸存者泌尿系统不良事件和勃起功能障碍的分析
Eur Urol Open Sci. 2024 Feb 23;62:26-35. doi: 10.1016/j.euros.2024.01.003. eCollection 2024 Apr.
6
Continuous Psychological Nursing Based on Grey Clustering Algorithm in Patients after Transurethral Resection of Prostate.基于灰色聚类算法的前列腺切除术后患者持续心理护理。
Comput Math Methods Med. 2022 Jul 28;2022:5400479. doi: 10.1155/2022/5400479. eCollection 2022.
7
Predictors for lower urinary tract symptoms in patients underwent radical prostatectomy: implications for postoperative nursing care.根治性前列腺切除术患者下尿路症状的预测因素:对术后护理的启示。
J Clin Nurs. 2022 May;31(9-10):1267-1272. doi: 10.1111/jocn.15981. Epub 2021 Sep 12.
8
Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy.术前运动干预以优化根治性前列腺切除术后的控尿效果。
Nat Rev Urol. 2021 May;18(5):259-281. doi: 10.1038/s41585-021-00445-5. Epub 2021 Apr 8.
9
Recurrent transient global amnesia after intracavernous Caverject injection in erectile dysfunction after robotic prostatectomy.机器人前列腺切除术后勃起功能障碍患者使用阴茎海绵体内注射凯威捷后出现复发性短暂性全面遗忘症。
Urol Case Rep. 2020 Apr 2;31:101184. doi: 10.1016/j.eucr.2020.101184. eCollection 2020 Jul.